Treating psoriasis by targeting its susceptibility gene Rel

Copyright © 2016 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 165(2016) vom: 15. Apr., Seite 47-54
1. Verfasser: Fan, Tingting (VerfasserIn)
Weitere Verfasser: Wang, Shaowen, Yu, Linjiang, Yi, Huqiang, Liu, Ruiling, Geng, Wenwen, Wan, Xiaochun, Ma, Yifan, Cai, Lintao, Chen, Youhai H, Ruan, Qingguo
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't IL-17A PEG-PLL-PLLeu micelles Psoriasis c-Rel siRNA RNA, Small Interfering RNA-Induced Silencing Complex
LEADER 01000naa a22002652 4500
001 NLM258583703
003 DE-627
005 20231224185324.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2016.03.009  |2 doi 
028 5 2 |a pubmed24n0861.xml 
035 |a (DE-627)NLM258583703 
035 |a (NLM)26993753 
035 |a (PII)S1521-6616(16)30037-7 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Fan, Tingting  |e verfasserin  |4 aut 
245 1 0 |a Treating psoriasis by targeting its susceptibility gene Rel 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 31.08.2016 
500 |a Date Revised 19.04.2016 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2016 Elsevier Inc. All rights reserved. 
520 |a Psoriasis is a chronic inflammatory disorder of the skin. Accumulating evidence indicates that the Rel gene, a member of the NF-κB family, is a risk factor for the disease. We sought to investigate whether psoriasis can be prevented by directly targeting the Rel gene transcript, i.e., the c-Rel mRNA. Using chemically-modified c-Rel specific siRNA (siRel) and poly(ethylene glycol)-b-poly(l-lysine)-b-poly(l-leucine) (PEG-PLL-PLLeu) micelles, we successfully knocked down the expression of c-Rel, and showed that the expression of cytokine IL-23, a direct target of c-Rel that can drive the development of IL-17-producing T cells, was markedly inhibited. More importantly, treating mice with siRel not only prevented but also ameliorated imiquimod (IMQ)-induced psoriasis. Mechanistic studies showed that siRel treatment down-regulated the expression of multiple inflammatory cytokines. Taken together, these results indicate that the susceptibility gene Rel can be targeted to treat and prevent psoriasis 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a IL-17A 
650 4 |a PEG-PLL-PLLeu micelles 
650 4 |a Psoriasis 
650 4 |a c-Rel 
650 4 |a siRNA 
650 7 |a RNA, Small Interfering  |2 NLM 
650 7 |a RNA-Induced Silencing Complex  |2 NLM 
700 1 |a Wang, Shaowen  |e verfasserin  |4 aut 
700 1 |a Yu, Linjiang  |e verfasserin  |4 aut 
700 1 |a Yi, Huqiang  |e verfasserin  |4 aut 
700 1 |a Liu, Ruiling  |e verfasserin  |4 aut 
700 1 |a Geng, Wenwen  |e verfasserin  |4 aut 
700 1 |a Wan, Xiaochun  |e verfasserin  |4 aut 
700 1 |a Ma, Yifan  |e verfasserin  |4 aut 
700 1 |a Cai, Lintao  |e verfasserin  |4 aut 
700 1 |a Chen, Youhai H  |e verfasserin  |4 aut 
700 1 |a Ruan, Qingguo  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 165(2016) vom: 15. Apr., Seite 47-54  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:165  |g year:2016  |g day:15  |g month:04  |g pages:47-54 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2016.03.009  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 165  |j 2016  |b 15  |c 04  |h 47-54